Clinical research
Clinical Research Map
Clinical trial sites: one pin for each physical site that hosts trials, placed from the address on the trial registration.
- Trial site
- Group of pins (click to zoom)
Showing 7,809 located sites.
Each pin is one trial site, placed on the map from the address on the trial registration, so it shows part of where trials are run, not all of it. A site with no located address has no pin. A site with a public page on Pharma Observatory links to it; other sites show name, place and trial count only.
Looking for contract research suppliers and CROs? Visit Contract Research Map
Trial sites by region
Select a bar to filter by region.
Log scale: bar lengths compare orders of magnitude, not proportions.
| Category | Trial sites |
|---|---|
| Latin America | 7,809 |
Top countries
Country of the site's address. Select a bar to filter.
Log scale: bar lengths compare orders of magnitude, not proportions.
Bar colour shows the country's region, as in the chart by region.
| Category | Trial sites |
|---|---|
| United States | 306,670 |
| Germany | 73,127 |
| France | 73,097 |
| Italy | 48,361 |
| China | 45,791 |
| Japan | 38,701 |
| Spain | 36,382 |
| United Kingdom | 32,384 |
Trial sites
7,809 sites. Sites with a public page link to it on Pharma Observatory.
-
Hospital Aleman 21 trials
-
Hospital Italiano de Buenos Aires 21 trials
-
Novo Nordisk Investigational Site 21 trials
-
Research Site 21 trials
-
Research Site 21 trials
-
Novartis Investigative Site 20 trials
-
Research Site 20 trials
-
Research Site 20 trials
-
Centro Medico Privado de Reumatologia 19 trials
-
Fundacion Scherbovsky 19 trials
-
Research Site 19 trials
-
GSK Investigational Site 18 trials
-
Instituto Médico Catamarca IMEC 18 trials
-
Instituto Médico Río Cuarto 18 trials
-
Local Institution 18 trials
-
Novartis Investigative Site 18 trials
-
Sanatorio Parque 18 trials
Explore the data behind the map on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.